<SEC-DOCUMENT>0001607062-14-000138-index.html : 20141017 <SEC-HEADER>0001607062-14-000138.hdr.sgml : 20141017 <ACCEPTANCE-DATETIME>20141017162309 ACCESSION NUMBER: 0001607062-14-000138 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20140731 FILED AS OF DATE: 20141017 DATE AS OF CHANGE: 20141017 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0314 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 141162121 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 </SEC-HEADER> <DOCUMENT> <TYPE>10-K/A <SEQUENCE>1 <FILENAME>gnbt20141014form10ka.htm <DESCRIPTION>FORM 10-K/A <TEXT> Document 1 - file: gnbt20141014form10ka.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-31.1 <SEQUENCE>2 <FILENAME>gnbt20141014form10kaex31_1.htm <DESCRIPTION>EXHIBIT 31.1 <TEXT> Document 2 - file: gnbt20141014form10kaex31_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-31.2 <SEQUENCE>3 <FILENAME>gnbt20141014form10kaex31_2.htm <DESCRIPTION>EXHIBIT 31.2 <TEXT> Document 3 - file: gnbt20141014form10kaex31_2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-32 <SEQUENCE>4 <FILENAME>gnbt20141014form10kaex32.htm <DESCRIPTION>EXHIBIT 32 <TEXT> Document 4 - file: gnbt20141014form10kaex32.htm
</DOCUMENT> </SEC-DOCUMENT>